Clinical efficacy of angiotensin receptor-neprilysin inhibitor in de novo heart failure with reduced ejection fraction

BACKGROUND/AIMS: We aimed to analyze the efficacy of angiotensin receptor-neprilysin inhibitor (ARNI) by the disease course of heart failure (HF). METHODS: We evaluated 227 patients with HF in a multi-center retrospective cohort that included those with left ventricular ejection fraction (LVEF) ≤ 40...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Su Yeong, Kong, Min Gyu, Moon, Inki, Park, Hyun Woo, Choi, Hyung-Oh, Seo, Hye Sun, Cho, Yoon Haeng, Lee, Nae-Hee, Lee, Kwan Yong, Jang, Ho-Jun, Kim, Je Sang, Choi, Ik Jun, Suh, Jon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association of Internal Medicine 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10493438/
https://www.ncbi.nlm.nih.gov/pubmed/37648226
http://dx.doi.org/10.3904/kjim.2023.065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10493438/
https://www.ncbi.nlm.nih.gov/pubmed/37648226
http://dx.doi.org/10.3904/kjim.2023.065

Ejemplares similares